← Back to work
Works cited by this work
213 works
Work: Emerging strategies to reduce the side effects of CAR-T cell therapy: focusing on gene editing and nanotechnology
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett +37
Article20172 citationsABIGene Editing and Genotoxicity: Targeting the Off-Targets
Georges Blattner, Alessia Cavazza, Adrian J. Thrasher +1
Review article20202 citationsABIEndowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing
Sumin Jo, Shipra Das, Alan F. Williams +19
Article20222 citationsABICurrent Strategies for Exosome Cargo Loading and Targeting Delivery
Haifeng Zeng, Shaoshen Guo, Xuancheng Ren +3
Review article20232 citationsABIThe paths toward non-viral CAR-T cell manufacturing: A comprehensive review of state-of-the-art methods
Yekta Metanat, Patrik Viktor, Ayesha Amajd +10
Review article20242 citationsABIFocusing on exosomes to overcome the existing bottlenecks of CAR-T cell therapy
Siheng Zhang, Linglong Peng, Yifei Chen +2
Review article20242 citationsABICD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in <i>TP53</i>
Karlo Perica, Nayan Jain, Michael Scordo +23
Article20252 citationsABI